CDA | Evidence Driven
CDA | Evidence Driven

Non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation

Details

Project Status:
In Progress
Therapeutic Area:
Non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0054-000

Review Type: Rapid

Provisional Funding Algorithm
Draft Report Posted (Target): 31-Oct-2024
Stakeholder Feedback Deadline (Target): 7-Nov-2024
Final Report Posted (Target): 4-Dec-2024
 
Last Updated : October 3, 2024